609PRomidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and exerts synergistic anti-tumour activity with an anti-PD-1 antibody in colon cancer
Li, HVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz246.086
Date:
October, 2019
File:
PDF, 677 KB
2019